Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
462
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Inc
•
03 Mar 2023 22:41
Celltrion (068270 KS): Disappointing 4Q22 Result; No Immediate Respite Is Seen
Celltrion reported Q4 result, with revenue, operating profit, and net profit declining YoY and QoQ. Continued pricing pressure, increasing...
Tina Banerjee
Follow
350 Views
Share
bullish
•
Quantitative Analysis
•
03 Mar 2023 08:00
Screening for GEMs: March 2023
This insight provides an overview of our, machine learning-driven, proprietary GEM screening model, based on a Multifactor model, a Deep Neural...
Wium Malan, CFA
Follow
199 Views
Share
bullish
•
Samsung Biologics
•
07 Jan 2023 15:41
Samsung Biologics (207940 KS): Near-Term Key Positive Catalysts
Upcoming participation in healthcare conference, Q4 result, and biosimilar launch in US are key catalysts to watch. Ongoing capex amid strong order...
Tina Banerjee
Follow
412 Views
Share
bullish
•
Celltrion Inc
•
17 Dec 2022 18:33
Celltrion Siblings Announced Dividends: Trading Based on Past Patterns
The three Celltrion companies all announced yearend dividends last Friday after the market closed. This post investigates past patterns for how we...
Sanghyun Park
Follow
497 Views
Share
bullish
•
Celltrion Inc
•
17 Dec 2022 03:19
Celltrion Group Companies - Sharp Increase in Dividends
Celltrion Inc, Celltrion Healthcare, and Celltrion Pharm all announced much higher dividend payments for this year as compared to last year.
Douglas Kim
Follow
540 Views
Share
First
Previous
24
25
26
27
28
29
30
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x